Register for OBR daily


IMS_White_300x250

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

CBMG $22.56 3.1600 +16.29%
ADXS $4.27 0.3900 +10.05%
ARWR $15.34 0.7700 +5.28%
ARGS $9.83 0.4400 +4.69%
AMBI $7.92 0.3500 +4.62%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

EXEL $1.85 -2.2900 -55.31%
ZIOP $3.00 -0.2300 -7.12%
IDRA $2.70 -0.1900 -6.57%
ONCY $1.30 -0.0800 -5.80%
Kite $26.82 -1.4500 -5.13%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | Next > | Last >>

Amgen Drug Fails to Improve Survival in Multiple Myeloma Trial

(Reuters) Aug 13, 2014 - Amgen Inc's Kyprolis drug failed to extend survival compared to standard care in a trial involving patients with advanced multiple myeloma, a type of blood cancer that develops in the bone marrow.
read article 



Agios Gets FDA Fast-Track Designation For Its Experimental Leukemia Drug

(Boston Globe) Aug 13, 2014 - Agios Pharmaceuticals Inc., a Cambridge company seeking to develop new treatments for cancer, said Wednesday that the US Food and Drug Administration has granted a so-called “Fast Track” designation to its experimental treatment for a type of acute myelogenous leukemia, or AML.
read article (free registration required) 



Health Insurer Wellpoint Changes Name to Anthem

(Washington Post) Aug 12, 2014 - The nation’s second-biggest health insurer, Wellpoint, said Tuesday that it will change its name to Anthem Inc., the brand associated with most of the company’s best known health plans.
read article (free registration required) 



AstraZeneca Gets Pipeline Boost from Good Gout Drug Results

(Reuters UK) Aug 13, 2014 - AstraZeneca, which fended off a $118 billion (70.14 billion pounds) takeover approach from Pfizer in May, reported positive results for an experimental gout drug on Wednesday that could boost its sales modestly.
read article 



Risk of Diabetes Doubles as Disease Rises Sharply in U.S.

(Bloomberg) Aug 12, 2014 - Forty percent of Americans born from 2000 to 2011 will develop diabetes, double the risk of those born a decade earlier, signaling a sharp increase in the disease’s prevalence, researchers found.
read article 



FDA Examines Stem Cell Medicines

(The Hill) Aug 12, 2014 - The Food and Drug Administration said Tuesday it is investigating stem cell-based medicines to make sure they are safe.
read article 



Big Investors Ask Drug Maker Boards Not to Denigrate Biosimilars

(Wall Street Journal/Pharmalot blog) Aug 11, 2014 - A group of 19 institutional investors is asking the boards of more than two dozen drug makers and biotechs to agree to various business principles in hopes of supporting use of biosimilar medicines.
read article (paid subscription required) 



Large Companies See Health-care Insurance Costs Rising 6.5% for 2015

(MarketWatch/Health Exchange blog) Aug 13, 2014 - If you’re worried about Obamacare premiums rising an average 8% throughout the U.S. next year, consider that large employers expect to see increases in health benefit costs next year of about 6.5%.
read article 



3 Girls From Powerful Viral Photo Recreate Image Now That They Are All In Remission From Cancer

(Huffington Post) Aug 12, 2014 - Three little girls whose image brought a message of hope, strength and community to the Internet recently headed back into the photo studio. This time, however, the resulting photographs are pure joy.
read article 



Calling on Cancer’s A-Team

(Yahoo! Health/U.S. News & World Report) Aug 12, 2014 - The 68 hospitals designated as national cancer centers by the National Cancer Institute (cancer.gov), which are supported by taxpayer dollars, are a rich resource for patients everywhere.
read article 



Dendreon Shares Plunge on Concern Debt Won’t Be Repaid

(Bloomberg) Aug 12, 2014 - Dendreon Corp., the maker of prostate-cancer drug Provenge, plunged after the company said it’s considering steps that may leave the shares worthless.
read article 



Cellectar Ready to Move into Human Trials of Radiopharmaceutical for Multiple Myeloma

(MedCity News) Aug 12, 2014 - US Cellectar Biosciences Inc said Monday that it has submitted to the US FDA an Investigational New Drug Application (IND) to initiate a clinical trial to study its highly-selective, cancer-targeting radiopharmaceutical I-131-CLR1404 as a therapy of patients with relapsed/refractory multiple myeloma.
read article 



RedHill Biopharma Acquires Option for Phase II Pancreatic Cancer Drug RP101

(RedHill Biopharma) Aug 13, 2014 - RedHill Biopharma Ltd. and RESprotect GmbH today announced that they have entered into a binding exclusive option agreement for the acquisition of the oncology drug candidate RP101 and next generation compounds.
read corporate press release 



NW BIO Corrects Ongoing False Claims by Feuerstein About Phase III Trial of DCVAX®-L, and Interim Analysis

(MarketWatch) Aug 13, 2014 - Phase III trial is alive and well; "Hint of failure" a complete fabrication; No interim analysis of efficacy done; 55 patients' positive data independently collected.
read article 



Northwest Bio DC-Vax Study Changes Hint at Failure

(TheStreet) Aug 12, 2014 - It's obvious DC-Vax came up futile in the early look at the phase III study data, leaving almost no chance the experimental cancer vaccine would benefit patients.
read article 



CMS Releases Provisional Design of a New Oncology Payment Model

(COA) Aug 13, 2014 - CMS sent the following email to COA President Dr. Bruce Gould, Immediate Past President Dr. Mark Thompson, and other stakeholders who participated in providing input on oncology payment reform.
read article 



Synthetic Molecule Uses Salt to Trigger Self-destruction of Cancer Cells

(Gizmag.com) Aug 13, 2014 - A team of international researchers has developed a molecule capable of triggering cancer cell death by carrying chloride into cancer cell membranes. The molecule flushes the cells with salt and causes them to self-destruct, potentially paving the way for new types of anti-cancer drugs.
read article 



Tiny Pieces of Gold 'Boost Brain Cancer Therapy' in Lab

(BBC News) Aug 12, 2014 - Minuscule pieces of gold may help improve treatment for aggressive brain cancers, according to research published in the journal Nanoscale.
read article 



Hijacking the Brain's Blood Supply: Tumor Discovery Could Aid Treatment

(U-M Health System) Aug 12, 2014 - Gliomas don’t grow their own blood vessels, U-M-led team finds.
read press release 



Researchers Reveal Weakness in Defenses of Deadly Brain Tumor

(Yale News) Aug 12, 2014 - Glioblastoma is a complex, deadly, and hard-to-treat brain cancer, but Yale School of Medicine researchers may have found the tumor’s Achilles heel.
read article 



Prostate Cancer Diagnosis Improves with MRI Technology

(UC San Diego) Aug 12, 2014 - Oncologists at UC San Diego Moores Cancer Center are the first in San Diego to meld magnetic resonance imaging (MRI) technology with a traditional ultrasound prostate exam to create a three-dimensional map of the prostate that allows physicians to view growths that were previously undetectable.
read press release 



CRI Scientists Pinpoint Gene Likely to Promote Childhood Cancers

(UT Southwestern/Children's Research Institute) Aug 11, 2014 - The gene Lin28b is expressed in several childhood cancers, including neuroblastoma, Wilms’ tumor and hepatoblastoma, a type of cancer that accounts for nearly 80 percent of all liver tumors in children according to Dr. Hao Zhu, a principal investigator at CRI.
read press release 



After Childhood Cancer, Young Women's Sexual Health May Suffer

(Reuters Health) Aug 12, 2014 - Adult women who survived cancer as a child report having less sex, less interest, less desire and less satisfaction than their sisters who never had cancer, according to a new study.
read article 



'Vanished' in US, Sigmoidoscopy Saves Lives in Norway

(Medscape Medical News) Aug 12, 2014 - Colorectal cancer screening with flexible sigmoidoscopy cuts incidence and deaths, according to yet another major trial.
read article (free registration required) 



Mayo Study Finds Less Radical Procedures Offer Similar Cancer Control Compared to Surgery for Kidney Cancer Patients

(Mayo Clinic) Aug 12, 2014 - Needle-guided tumor destruction procedures offer near equivalent lengths of local cancer control compared to surgery for patients with small kidney cancer tumors, according to the results of a large study published in the journal European Urology.
read press release